Development and Validation of an Algorithm for Identifying Patients with Hemophilia A in an Administrative Claims Database-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and Validation of an Algorithm for Identifying Patients with Hemophilia A in an Administrative Claims Database

Published:2018-09 Issue:9 Volume:21 Page:1098-1103
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Lyons Jennifer,Desai Vibha,Xu Yaping,Ridgeway Greg,Finkle William,Solari Paul,Sullivan Sean,Lanes Stephan

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference12 articles.

1. Management of musculoskeletal complications of hemophilia;Rodriguez-Merchan;Semin Thromb Hemost,2003

2. Costs and utilization of hemophilia A and B patients with and without inhibitors;Armstrong;J Med Econ,2014

3. Healthcare expenditures for males with haemophilia and employer-sponsored insurance in the United States, 2008;Guh;Haemophilia,2012

4. Medical costs and resource utilization for hemophilia patients with and without HIV or HCV infection;Tencer;J Manag Care Pharm,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health care costs and resource use of managing hemophilia A: A targeted literature review;Journal of Managed Care & Specialty Pharmacy;2023-06

2. A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors;Expert Review of Hematology;2023-04-28

3. Impact of switching prophylaxis treatment from factor VIII to emicizumab in hemophilia A patients without inhibitors;Journal of Medical Economics;2023-04-17

4. The anatomical therapeutic chemical classification is flexible enough to describe the innovation in biotechnological drugs?;2023-02-07

5. Early real-world experience with emicizumab and concomitant factor VIII replacement products in adult males with Hemophilia A without inhibitors;Journal of Medical Economics;2022-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3